Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2026 ASTRO Annual Meeting
IASLC WCLC 2026
2026 ASCO GI
ASCO Breakthrough 2026
ASCO 2026
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2020 ASH Annual Meeting
«
1
»
Advertisement
Advertisement
Sep
28
Today In Oncology
FDA Advisory Committee Votes In Favor of Approval of Multi-Cancer Early Detection Test
SRS Is a Reasonable Option for Patients With SCLC and Brain Metastases
Fractionated SRS Approach Improves Outcomes for Patients With Resected Large Brain Metastases
Adding Targeted Immunotherapy to Pembrolizumab in Recurrent or Metastatic HPV16-Positive Head and Neck Squamous Cell Carcinoma
Phase III Trial Compares HER2-Directed Antibody-Drug Conjugates in Advanced Breast Cancer
View More
Advertisement